These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8118457)
41. [Results of the ECHODIAH clinical trial on hip arthrosis]. Vignon E Presse Med; 2002 Jan; 31(1 Pt 2):7-9. PubMed ID: 11826591 [TBL] [Abstract][Full Text] [Related]
42. Effect of diacetyl rhein on the development of experimental osteoarthritis. A biochemical investigation. Carney SL Osteoarthritis Cartilage; 1996 Dec; 4(4):251-61. PubMed ID: 11048622 [TBL] [Abstract][Full Text] [Related]
43. The mechanism of action of nonsteroidal antiinflammatory drugs. Brandt KD J Rheumatol Suppl; 1991 Feb; 27():120-1. PubMed ID: 2027109 [TBL] [Abstract][Full Text] [Related]
44. Pharmacological therapy of osteoarthritis. Hochberg MC; Dougados M Best Pract Res Clin Rheumatol; 2001 Oct; 15(4):583-93. PubMed ID: 11567541 [TBL] [Abstract][Full Text] [Related]
45. Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures. Yaron M; Shirazi I; Yaron I Osteoarthritis Cartilage; 1999 May; 7(3):272-80. PubMed ID: 10329302 [TBL] [Abstract][Full Text] [Related]
46. Is there preliminary in-vivo evidence for an influence of nonsteroidal antiinflammatory drugs on progression in osteoarthritis? Part II-evidence from animal models. Serni U; Mannoni A; Benucci M Osteoarthritis Cartilage; 1999 May; 7(3):351-2. PubMed ID: 10329329 [No Abstract] [Full Text] [Related]
47. [Pharmacy clinics. How I treat...Osteoarthritis. 2nd part: new therapeutic perspectives]. Reginster JY; Henrotin Y Rev Med Liege; 2001 Mar; 56(3):135-9. PubMed ID: 11338782 [TBL] [Abstract][Full Text] [Related]
48. [Cartilage changes in arthrosis--do non-steroidal antiphlogistics have positive or negative effects?]. Ostensen M Tidsskr Nor Laegeforen; 1991 Mar; 111(7):838-40. PubMed ID: 2020951 [TBL] [Abstract][Full Text] [Related]
50. Diacerhein attenuates the inflammatory response and improves survival in a model of severe sepsis. Calisto KL; Camacho AC; Mittestainer FC; Carvalho BM; Guadagnini D; Carvalheira JB; Saad MJ Crit Care; 2012 Aug; 16(4):R158. PubMed ID: 22897821 [TBL] [Abstract][Full Text] [Related]
51. Inhibition of interleukin-1beta-induced activation of MEK/ERK pathway and DNA binding of NF-kappaB and AP-1: potential mechanism for Diacerein effects in osteoarthritis. Domagala F; Martin G; Bogdanowicz P; Ficheux H; Pujol JP Biorheology; 2006; 43(3,4):577-87. PubMed ID: 16912429 [TBL] [Abstract][Full Text] [Related]
52. [Study of ART 50 in daily rheumatological practice]. Delcambre B; Taccoen A Rev Prat; 1996 Mar; 46(6 Spec No):S49-S52. PubMed ID: 8731732 [No Abstract] [Full Text] [Related]
53. [The pathogenetic substantiation of new therapeutic approach to the treatment of secondary osteoarthritis in patients with rheumatoid arthritis with basis therapy]. Starodubtseva IA; Tsvetikova LN Adv Gerontol; 2014; 27(3):531-6. PubMed ID: 25827002 [TBL] [Abstract][Full Text] [Related]
55. Antireactive properties of "chondroprotective" drugs. Setnikar I Int J Tissue React; 1992; 14(5):253-61. PubMed ID: 1300311 [TBL] [Abstract][Full Text] [Related]
56. Preliminary experience with diacetylrhein in the treatment of osteoarthritis. Kay AG; Griffiths LG; Volans GN; Grahame R Curr Med Res Opin; 1980; 6(8):548-51. PubMed ID: 7389385 [TBL] [Abstract][Full Text] [Related]
57. Diacerhein downregulate proinflammatory cytokines expression and decrease the autoimmune diabetes frequency in nonobese diabetic (NOD) mice. Malaguti C; Vilella CA; Vieira KP; Souza GH; Hyslop S; Zollner Rde L Int Immunopharmacol; 2008 Jun; 8(6):782-91. PubMed ID: 18442781 [TBL] [Abstract][Full Text] [Related]
58. Targeting of diacerein loaded lipid nanoparticles to intra-articular cartilage using chondroitin sulfate as homing carrier for treatment of osteoarthritis in rats. Jain A; Mishra SK; Vuddanda PR; Singh SK; Singh R; Singh S Nanomedicine; 2014 Jul; 10(5):1031-40. PubMed ID: 24512762 [TBL] [Abstract][Full Text] [Related]
59. The effects of orally administered diacerein on cartilage and subchondral bone in an ovine model of osteoarthritis. Hwa SY; Burkhardt D; Little C; Ghosh P J Rheumatol; 2001 Apr; 28(4):825-34. PubMed ID: 11327258 [TBL] [Abstract][Full Text] [Related]
60. [Assessment of the placebo effect of symptomatic slow-acting anti-arthritics]. Villani P; Bouvenot G Presse Med; 1998 Feb; 27(5):211-4. PubMed ID: 9768015 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]